Background and objectives: Chronic kidney disease (CKD) has recently assumed epidemic
proportion, becoming a troubling emerging cause of morbidity, especially if it progresses to
terminal stage (ESRD). The authors aimed to evaluate whether neutrophil gelatinase-
associated lipocalin (NGAL), a novel specific biomarker of acute kidney injury, could predict
the progression of CKD.